Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement

Eur J Clin Invest. 2022 Sep;52(9):e13808. doi: 10.1111/eci.13808. Epub 2022 May 12.

Tetsuya Suzuki^{1

2}, Noriko Iwamoto^{1

2}, Shinya Tsuzuki^{1

3}, Yuko Kakumoto¹, Michiyo Suzuki¹, Shinobu Ashida¹, Yusuke Oshiro⁴, Takeshi Nemoto⁴, Kohei Kanda¹, Ayako Okuhama¹, Gen Yamada¹, Makoto Inada¹, Lubna Sato¹, Yusuke Miyazato¹, Yutaro Akiyama¹, Sho Saito^{1

2}, Shinichiro Morioka^{1

2}, Mugen Ujiie¹, Kayoko Hayakawa¹, Masaya Sugiyama^{5

6}, Masashi Mizokami⁵, Eiichi N Kodama⁷, Norio Ohmagari^{1

2}

¹ Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
² Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
³ Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
⁴ Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
⁵ Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Ichikawa, Japan.
⁶ Department of Viral Pathogenesis and Controls, National Center for Global Health and Medicine, Ichikawa, Japan.
⁷ Department of Infectious Disease, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

No abstract available

Publication types